3-Aminooxetane-3-carboxylic acid, 95.0%, 5g

2,3-Dicyanopyrazine>99.0%(GC)25g

4-Morpholin-4-yl-4-oxo-butyric acid, 98.0%, 5g

(10-Phenylanthracen-9-yl)boronic acid, 95.0%, 10g

Cyclopentanecarbonyl chloride, 98.0%, 1g

tert-Butyl 4-benzyl-1-oxa-4,8-diazaspiro[5.5]undecane-8-carboxylate, 98%, 100mg

1-(2-Trifluoromethylbenzyl)-1H-pyrazole-4-carboxylic acid, 1g

9,10-Dioxo-9,10-dihydro-anthracene-2,6-dicarboxylic acid, 97%, 1g

Colonne capillaire GC ROTI®Cap-1, 50 m, 0,32 mm, 0,35 µm, 1 pièce(s)

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 250mg

2,6-Di-tert-butyl-4-methylpyridine>98.0%(GC)(T)5g

tert-Butylphosphonic Dichloride>98.0%(GC)1g

2(1H)-QUINOLINONE, 6-CHLORO-3,4-DIHYDRO-4-METHYL-, 95.0%, 1g